Expand SRPT Menu
SRPT MENU

SRPT Stock Summary and Trading Ideas (Sarepta Therapeutics | NASDAQ:SRPT)

Charts for Today's Stock Price and Implied Volatility in Sarepta Therapeutics

24-Apr-2024

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for SRPT by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Sarepta Therapeutics (SRPT) Frequently Asked Questions

What does Sarepta Therapeutics do?

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.

What symbol and exchange does Sarepta Therapeutics stock trade?

Sarepta Therapeutics trades on the NASDAQ stock market under the symbol SRPT.

What is Sarepta Therapeutics stock price doing today?

As of April 24, 2024, SRPT stock price climbed to $124.25 with 1,246,359 million shares trading.

What is Sarepta Therapeutics's Beta?

SRPT has a beta of 0.09, meaning it tends to be less sensitive to market movements. SRPT has a correlation of 0.00 to the broad based SPY ETF.

How much is Sarepta Therapeutics worth?

SRPT has a market cap of $11.57 billion. This is considered a Large Cap stock.

How much money does Sarepta Therapeutics make?

Last quarter Sarepta Therapeutics reported $397 million in Revenue and $.82 earnings per share. This beat revenue expectation by $11 million and exceeded earnings estimates by $.81.

What is the highest and lowest price Sarepta Therapeutics traded in the last 3 year period?

In the last 3 years, SRPT stock traded as high as $159.89 and as low as $55.25.

What are the top ETFs holding Sarepta Therapeutics?

The top ETF exchange traded funds that SRPT belongs to (by Net Assets): VTI, VB, VXF, VBK, IBB.

Is Sarepta Therapeutics (SRPT) a good investment?

SRPT has underperformed the market in the last year with a return of -1.9%, while the SPY ETF gained +24.1%. In the last 3 month period, SRPT fell short of the market, returning +3.4%, while SPY returned +4.5%. However, in the most recent 2 weeks SRPT has outperformed the stock market by returning -1.6%, while SPY returned -1.7%.

What is the support and resistance for Sarepta Therapeutics (SRPT) stock price?

SRPT support price is $114.71 and resistance is $119.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SRPT stock will trade within this expected range on the day.